Prot#XL147-202: A Phase 1/2 Dose-Escalation Study of XL147 or XL765 in Combination with Letrozole in Subjects with Hormone Receptor-Positive and HER2-Negative Breast Cancer Refractory to a Nonsteroidal Aromatase Inhibitor

Project: Research project

Project Details

StatusFinished
Effective start/end date8/17/11 → 12/20/16

Funding

  • Sanofi US Services Inc. (XL147-202)